Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,844.48
(
0.40%
)
US TECH 100
24,551.60
(
0.45%
)
Dow Jones
47,912.94
(
-0.01%
)
Brent Oil
97.05
(
-2.81%
)
Bitcoin
72,383.91
(
2.27%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: cheynew post# 205532

Friday, 02/06/2015 2:34:04 PM

Friday, February 06, 2015 2:34:04 PM

Post# of 347009
ok we can agree to disagree. I will take this advise though and next time I go see my MD and even though I see his diploma on the wall and I know they must carry insurance... I will go further and ask him for an updated copy of transcript as proof and update insurance policy as proof.

I wonder what the judge thinks...

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote